Evidence mapPaperPMID 41301462Full record

ReviewBiomolecules2025

The Impact of Glycaemic Variability on Vascular Dysfunction in Diabetes.

Laura J Offler, Liz K Wells, Timothy M Palmer

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura J OfflerBiomedical Institute for Multimorbidity, Hull York Medical School Centre for Biomedicine, Faculty of Health Sciences, University of Hull, Hull HU6 7RX, UK.ORCID 0009-0004-6914-7438
Liz K WellsSchool of Rehabilitation and Sport Sciences, Faculty of Health Sciences, University of Hull, Hull HU6 7RX, UK.ORCID 0000-0003-1797-2300
Timothy M PalmerBiomedical Institute for Multimorbidity, Hull York Medical School Centre for Biomedicine, Faculty of Health Sciences, University of Hull, Hull HU6 7RX, UK.ORCID 0000-0002-9803-7164

Funding

University of Hull PhD studentship
6 · The paper itself

Abstract

It is well established that vascular dysfunction is common in people with diabetes mellitus and is associated with increased risk of heart attack, ischaemic stroke and peripheral vascular disease. Although our understanding of the molecular mechanisms responsible is incomplete, persistent hyperglycaemia observed in poorly controlled diabetes has long been thought to be a critical factor. Multiple studies have, therefore, investigated the effects of poor glycaemic control on vascular function in multiple experimental settings, from in vitro and ex vivo models of primary human cells and tissues through to pre-clinical models. This review consolidates our current understanding of how metabolic and cell signalling pathways triggered by poor glycaemic control, impact vascular function in diabetes. We also evaluate how these pathways could be exploited to develop targeted therapeutic approaches to improve cardiovascular outcomes specifically in people with diabetes.

Indexed as

Cardiovascular DiseasesCardiovascular SystemDiabetes MellitusGlycemic ControlAnimalsBlood GlucoseDisease Models, AnimalHumansRiskBlood Glucosecardiovascular dysfunctiondiabetesendothelial dysfunctionglycaemic variationvascular regulation

Identifiers

PMID41301462
PMCPMC12650407

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.